Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19)
Objective Dipeptidase-1 (DPEP-1) is a recently discovered leucocyte adhesion receptor for neutrophils and monocytes in the lungs and kidneys and serves as a potential therapeutic target to attenuate inflammation in moderate-to-severe COVID-19. We aimed to evaluate the safety and efficacy of the DPEP...
Main Authors: | Alain Tremblay, Ranjani Somayaji, Arthur Lau, Fatma Eser, Rahmet Guner, David R Luke, Ŏ Fehmi Tabak, Mark Hepokoski, Nancy Gardetto, Steven A Conrad, Sunil D Kumar, Kalyan Ghosh, Stephen M Robbins, Donna L Senger, Daisy Sun, Rachel K S Lim, Jonathan Liu, Ridvan Karaali, Daniel Muruve |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-03-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/3/e076142.full |
Similar Items
-
Targeting Mitochondria and Metabolism in Acute Kidney Injury
by: Ying Li, et al.
Published: (2021-09-01) -
Modeling the Health Economic Burden of Hepatitis C Virus Infection in Turkey: Cost-Effectiveness of Targeted Screening
by: Ayhan Hilmi Çekin, et al.
Published: (2023-10-01) -
Multicentre Acute Stroke Trial--Italy.
by: Rothwell, P
Published: (1996) -
Just breathe: a review of sex and gender in chronic lung disease
by: Ranjani Somayaji, et al.
Published: (2022-01-01) -
Eccrine chromhidrosis in severe acute respiratory syndromecoronavirus- 2 virus infection treated with favipiravir
by: Müge Göre Karaali, et al.
Published: (2022-09-01)